Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels
Authors:
Open Access
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 19 (5) , 102515
Abstract
No abstract availableKeywords
Funding Information
- Stichting RUN (R 0003057)
This publication has 38 references indexed in Scilit:
- Personalizing medicine: Futures present and pastSocial Science & Medicine, 2012
- Signaling by IL-31 and functional consequencesEuropean Journal of Cell Biology, 2012
- Anti-Th/To Are Common Antinucleolar Autoantibodies in Italian Patients with SclerodermaThe Journal of Rheumatology, 2010
- Scleroderma Renal Crisis: A Pathology PerspectiveInternational Journal of Rheumatology, 2010
- Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double‐blind, randomized controlled trialsArthritis & Rheumatism, 2009
- The Many Faces of SclerodermaRheumatic Disease Clinics of North America, 2008
- Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory modelArthritis & Rheumatism, 2007
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- Evidence‐based guidelines for the use of immunologic tests: Anticentromere, Scl‐70, and nucleolar antibodiesArthritis Care & Research, 2003
- Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysisArthritis & Rheumatism, 1996